The genes encoding virulence-associated proteins and the capsule of Streptococcus pneumoniae are upregulated and differentially expressed in vivo

Alexander, 1994, Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae, Infect Immun, 62, 5683, 10.1128/IAI.62.12.5683-5688.1994

Austrian, 1981, Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention, Rev Infect Dis, 3, S1, 10.1093/clinids/3.Supplement_1.S1

Avery, 1944, Studies on the chemical nature of the substance inducing transformation of pneumococcal types. Induction of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III, J Exp Med, 79, 137, 10.1084/jem.79.2.137

Bentley, 1991, Intrageneric structure of Streptococcus based on comparative analysis of small-subunit rRNA sequences, Int J Syst Bacteriol, 41, 487, 10.1099/00207713-41-4-487

Benton, 1995, A pneumolysin-negative mutant of Streptococcus pneumoniae causes chronic bacteremia rather than acute sepsis in mice, Infect Immun, 63, 448, 10.1128/IAI.63.2.448-455.1995

Berry, 1996, Sequence heterogeneity of PsaA, a 37-kDa putative adhesin essential for virulence of Streptococcus pneumoniae, Infect Immun, 64, 5255, 10.1128/IAI.64.12.5255-5262.1996

Berry, 2000, Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins, Infect Immun, 68, 133, 10.1128/IAI.68.1.133-140.2000

Berry, 1989, Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae, Infect Immun, 57, 2037, 10.1128/IAI.57.7.2037-2042.1989

Berry, 1999, Comparative virulence of Streptococcus pneumoniae strains with insertion-duplication, point, and deletion mutations in the pneumolysin gene, Infect Immun, 67, 981, 10.1128/IAI.67.2.981-985.1999

Boulnois, 1992, Pneumococcal proteins and the pathogenesis of disease caused by Streptococcus pneumoniae, J Gen Microbiol, 138, 249, 10.1099/00221287-138-2-249

Boulnois, 1991, Structure and function of pneumolysin, the multifunctional, thiol-activated toxin of Streptococcus pneumoniae, Mol Microbiol, 5, 2611, 10.1111/j.1365-2958.1991.tb01969.x

Briles, 2000a, Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae, Infect Immun, 68, 796, 10.1128/IAI.68.2.796-800.2000

Briles, 2000b, The potential to use PspA and other pneumococcal proteins to elicit protection against pneumococcal infection, Vaccine, 18, 1707, 10.1016/S0264-410X(99)00511-3

Brooks-Walter, 1999, The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia, Infect Immun, 67, 6533, 10.1128/IAI.67.12.6533-6542.1999

Claverys, 1999, Penicillin tolerance in Streptococcus pneumoniae , autolysis and the Psa ATP-binding cassette (ABC) manganese permease, Mol Microbiol, 32, 881, 10.1046/j.1365-2958.1999.01369.x

Dintilhac, 1997, Competence and virulence of Streptococcus pneumoniae : Adc and PsaA mutants exhibit a requirement for Zn and Mn resulting from inactivation of putative ABC metal permeases, Mol Microbiol, 25, 727, 10.1046/j.1365-2958.1997.5111879.x

Feldman, 1990, The effect of Streptococcus pneumoniae pneumolysin on human respiratory epithelium in vitro, Microb Pathog, 9, 275, 10.1016/0882-4010(90)90016-J

Ferrante, 1984, Inhibition of in vitro human lymphocyte response by the pneumococcal toxin pneumolysin, Infect Immun, 46, 585, 10.1128/IAI.46.2.585-589.1984

Garenne, 1992, The magnitude of mortality from acute respiratory infections in children under 5 years in developing countries, World Health Stat Q, 46, 180

Gosink, 2000, Role of novel choline binding proteins in virulence of Streptococcus pneumoniae, Infect Immun, 68, 5690, 10.1128/IAI.68.10.5690-5695.2000

Hammerschmidt, 1997, SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component, Mol Microbiol, 25, 1113, 10.1046/j.1365-2958.1997.5391899.x

Hammerschmidt, 1999, Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae, Infect Immun, 67, 1683, 10.1128/IAI.67.4.1683-1687.1999

Hammerschmidt, 2000, Species-specific binding of human secretory component to SpsA protein of Streptococcus pneumoniae via a hexapeptide motif, Mol Microbiol, 36, 726, 10.1046/j.1365-2958.2000.01897.x

Houldsworth, 1994, Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes, Infect Immun, 62, 1501, 10.1128/IAI.62.4.1501-1503.1994

Iannelli, 1999, The type 2 capsule locus of Streptococcus pneumoniae, J Bacteriol, 181, 2652, 10.1128/JB.181.8.2652-2654.1999

Jakubovics, 2000, Expression of the virulence-related Sca (Mn2+) permease in Streptococcus gordonii is regulated by a diphtheria toxin metallorepressor-like protein ScaR, Mol Microbiol, 38, 140, 10.1046/j.1365-2958.2000.02122.x

Kim, 1998, Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae, J Infect Dis, 177, 368, 10.1086/514205

Lankinen, 1999, Pneumococcal pneumonia diagnosis by demonstration of pneumolysin antibodies in precipitated immune complexes: a study in 350 Philippine children with acute lower respiratory infection, Scand J Infect Dis, 31, 155, 10.1080/003655499750006209

Lawrence, 1998, The crystal structure of pneumococcal surface antigen PsaA reveals a metal-binding site and a novel structure for a putative ABC-type binding protein, Structure, 6, 1553, 10.1016/S0969-2126(98)00153-1

McDaniel, 1987, Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA, J Exp Med, 165, 381, 10.1084/jem.165.2.381

Mitchell, 1991, Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein, Mol Microbiol, 5, 1883, 10.1111/j.1365-2958.1991.tb00812.x

Mortier-Barrière, 1998, Competence-specific induction of recA is required for full recombination proficiency during transformation in Streptococcus pneumoniae, Mol Microbiol, 27, 159, 10.1046/j.1365-2958.1998.00668.x

Musher, 1992, Infections caused by Streptococcus pneumoniae : clinical spectrum, pathogenesis, immunity, and treatment, Clin Infect Dis, 14, 801, 10.1093/clinids/14.4.801

Novak, 1998, Penicillin tolerance genes of Streptococcus pneumoniae : the ABC-type manganese permease complex Psa, Mol Microbiol, 29, 1285, 10.1046/j.1365-2958.1998.01016.x

Obaro, 2000, Prospects for pneumococcal vaccination in African children, Acta Trop, 75, 141, 10.1016/S0001-706X(99)00094-7

Ogunniyi, 2000, Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae, Infect Immun, 68, 3028, 10.1128/IAI.68.5.3028-3033.2000

Orihuela, 2000, Peritoneal culture alters Streptococcus pneumoniae protein profiles and virulence properties, Infect Immun, 68, 6082, 10.1128/IAI.68.10.6082-6086.2000

Paton, 1996, The contribution of pneumolysin to the pathogenicity of Streptococcus pneumoniae, Trends Microbiol, 4, 103, 10.1016/0966-842X(96)81526-5

Paton, 1998, Novel pneumococcal surface proteins: role in virulence and vaccine potential, Trends Microbiol, 6, 85, 10.1016/S0966-842X(98)01220-7

Paton, 1983, Inhibition of human polymorphonuclear leukocyte respiratory burst, migration and bactericidal activity by the pneumococcal toxin, pneumolysin, Infect Immun, 41, 1212, 10.1128/IAI.41.3.1212-1216.1983

Paton, 2000, Streptococcus pneumoniae capsular polysaccharide, Gram-Positive Pathogens, 201

Paton, 1984, Activation of human complement by the pneumococcal toxin, pneumolysin, Infect Immun, 43, 1085, 10.1128/IAI.43.3.1085-1087.1984

Paton, 1993, Molecular analysis of the pathogenicity of Streptococcus pneumoniae : the role of pneumococcal proteins, Annu Rev Microbiol, 47, 89, 10.1146/annurev.mi.47.100193.000513

Paton, 1997, Molecular analysis of putative pneumococcal virulence proteins, Microb Drug Resist, 3, 1, 10.1089/mdr.1997.3.1

Rapola, 2000, Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media, J Infect Dis, 182, 1146, 10.1086/315822

Ring, 1998, Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway, J Clin Invest, 102, 347, 10.1172/JCI2406

Rosenow, 1997, Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae, Mol Microbiol, 25, 819, 10.1111/j.1365-2958.1997.mmi494.x

Smith, 2000, C3 as substrate for adhesion of Streptococcus pneumoniae, J Infect Dis, 182, 497, 10.1086/315722

Talbot, 1996, Uptake of Streptococcus pneumoniae by respiratory epithelial cells, Infect Immun, 64, 3772, 10.1128/IAI.64.9.3772-3777.1996

Tu, 1999, Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae, Infect Immun, 67, 4720, 10.1128/IAI.67.9.4720-4724.1999

Tuomanen, 1995, The pathogenesis of pneumococcal infection: correlation of clinical events with molecular mechanisms, N Engl J Med, 332, 1280, 10.1056/NEJM199505113321907

Virolainen, 2000, Human antibodies to pneumococcal surface protein A in health and disease, Pediatr Infect Dis J, 19, 134, 10.1097/00006454-200002000-00011

Walker, 1987, Molecular cloning, characterization, and complete nucleotide sequence of the gene for pneumolysin, the sulfhydryl-activated toxin of Streptococcus pneumoniae, Infect Immun, 55, 1184, 10.1128/IAI.55.5.1184-1189.1987

Whitney, 2000, Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States, N Engl J Med, 343, 1917, 10.1056/NEJM200012283432603

1997, Global Programme for Vaccines and Immunization (Vaccine Research and Development). Report of The Technical Review Group Meeting, July 1997–June 1998; Achievements and Plan of Activities: Meningococcal and Pneumococcal Disease Vaccines, 26

Yother, 1992, Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae , as revealed by sequence analysis, J Bacteriol, 174, 601, 10.1128/JB.174.2.601-609.1992

Zhang, 2000, The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells, Cell, 102, 827, 10.1016/S0092-8674(00)00071-4